Skip to main content
. 2020 Jul 14;8:454. doi: 10.3389/fcell.2020.00454

TABLE 4.

In vivo antitumor activity in the MDA-MB-231 xenograft modela.

Compound TGI (%) T/C (%)
1 59 55
Vorinostat 33 78

aCompared with the control group, compound 1 showed statistically significant (p < 0.05) tumor growth inhibition (TGI) and relative increment ratio (T/C) by Student’s one-tailed t-test, and vorinostat showed no statistically significant (p > 0.05) TGI and T/C by Student’s one-tailed t-test. The TGI values are based on tumor weight.